Kazan medical journalKazan medical journal0368-48142587-9359Eco-Vector6530810.17816/kazmj65308Research ArticleDiucifonum treatment of patients with systemic sclerodermaAbdrakhmanovaR. Sh.info@eco-vector.comBilichI. L.info@eco-vector.comMangushevaM. M.info@eco-vector.comBombinaL. K.info@eco-vector.comKhalfievaG. M.info@eco-vector.comS.V. Kurashov Kazan Medical Institute1504198667296982304202123042021Copyright © 1986, Abdrakhmanova R.S., Bilich I.L., Mangusheva M.M., Bombina L.K., Khalfieva G.M.1986<p>The treatment of patients with systemic scleroderma is still a challenging task for internal medicine clinics. This paper presents the results of the therapeutic efficacy of diucciphone in such patients at different periods of observation. Diucciphone (2,4 dioxo-6-methylpyrimidinyl-5-sulfonoamido)-diphenylsulfone is an antileprosy drug synthesized at the A.E. Arbuzov Institute of Organic and Physical Chemistry, KFAN of the USSR.</p>Kazan Medical archiveКазанский медицинский архив